FIELD: medicine.
SUBSTANCE: melatonin MT-1 and MT-2 receptor expression is assessed in the cells of the gastric and/or duodenal mucosa to calculate the discriminant function by formula: D=1.127×MT1/MT2-4.005. If D>0, the developing complications are predicted, and D<0 shows the favourable clinical course of the disease.
EFFECT: method is high-specific and enables the more effective prediction.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING CLINIC COURSE OF PEPTIC GASTRODUODENAL ULCER AND ITS COMPLICATIONS | 2005 |
|
RU2284037C1 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF DESTRUCTIVE CHANGES OF GASTRODUODENTAL ZONE MUCOUS TUNIC | 2008 |
|
RU2391915C1 |
| METHOD OF PREDICTING GASTRODUODENAL PATHOLOGY COURSE IN CHILDREN | 2011 |
|
RU2475754C2 |
| METHOD FOR PREDICTION OF RISK OF GASTRIC AND DUODENAL ULCER DEVELOPMENT BASED ON MOLECULAR GENETIC TESTING | 2023 |
|
RU2816514C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING H. PYLORI-POSITIVE DUODENAL ULCER USING DATA ON MMP-9 GENE POLYMORPHISM | 2022 |
|
RU2782496C1 |
| METHOD FOR PREDICTING DEVELOPMENT COURSE OF ACUTE ULCERATION IN GASTRODUODENAL ZONE OF DIGESTIVE TRACT | 1998 |
|
RU2140087C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING DUODENAL ULCER BASED ON MOLECULAR GENETIC TESTING | 2023 |
|
RU2816519C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING GASTRIC AND DUODENAL ULCERS IN WOMEN BASED ON MOLECULAR GENETIC TESTING | 2023 |
|
RU2811577C1 |
| METHOD FOR TREATING INFLAMMATORY DEGENERATIVE STOMACH AND DUODENUM DISEASES | 2005 |
|
RU2289448C1 |
| METHOD FOR PREDICTING SEASONAL EXACERBATION OF DUODENAL ULCER | 2022 |
|
RU2787913C1 |
